In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal…

Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than before,…

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. The…

image:  The team have shown that their nanostructured surfaces resist the growth of bacteria, but enable the culturing of cells.…

Tokyo Metropolitan University has recently made a significant advancement in the realm of biomaterials through the development of anodic porous…

A significant breakthrough in the treatment of soil-transmitted helminthiases has emerged from a clinical trial led by the Barcelona Institute…

Researchers are heralding a significant breakthrough in the fight against intestinal parasites that afflict approximately 1.5 billion people globally. The…

In a groundbreaking initiative aimed at addressing disparities in neurological outcomes, UTHealth Houston has secured a significant grant of $2.9…

Depression is a complex and pervasive mental health disorder that can impact individuals regardless of their background or circumstances. Characterized…

A new era in the pursuit of healthier aging and the prevention of bone-related ailments has emerged from cutting-edge research…